Literature DB >> 26590573

Lentivirus-mediated knockdown of CTDP1 inhibits lung cancer cell growth in vitro.

Runbo Zhong1, Xiaoxiao Ge1, Tianqing Chu1, Jiajun Teng1, Bo Yan1, Jun Pei1, Liyan Jiang1, Hua Zhong2, Baohui Han3.   

Abstract

BACKGROUND: CTDP1 catalyzes serine phosphorylation and dephosphorylation of the mobile carboxy-terminal domain of the RNA polymerase II. It is conserved among eukarya and is essential for cell growth for its ability in regulation of transcription machinery. However, its function in the process of tumorigenesis is unclear. In the present study, we aim to explore the roles of CTDP1 in the progression of human lung cancer. To our knowledge, this is the first study that reports the functions of CTDP1 in human lung cancer.
METHODS: We first detected the expression level of CTDP1 in four human lung cancer cell lines: H-125, H1299, LTEP-A-2 and NCI-H446 by semiquantitative RT-PCR. We compared the expression level of CTDP1 in lung cancer tissues and paired adjacent normal tissues on 29 pathologically confirmed patients by real-time quantitative PCR. To further explore the effect of CTDP1 on cell proliferation, a lentiviral vector expressing CTDP1 short hairpin RNA (shRNA) was constructed and infected into human lung cell lines H1299. Interference efficiency was determined by western blot analysis and real-time quantitative PCR. The effects of knockdown of CTDP1 on cell growth, cell cycle and apoptosis and cell colony formation were explored by Cellomics, fluorescence-activated cells sorting and fluorescence microscopy, respectively.
RESULTS: CTDP1 was expressed in all four human lung cancer cell lines. The expression of CTDP1 in tumor tissues was significantly higher than paired adjacent normal tissues in 29 patients with lung cancer. The expression of CTDP1 was markedly reduced in cells infected with lentivirus delivering shRNA against CTDP1. Inhibition of CTDP1 expression significantly suppressed cell growth, induced G0/G1 phase arrest and repressed cell colony formation.
CONCLUSIONS: Our results demonstrated that CTDP1 was upregulated in human lung cancer tissues. In addition, it implied that CTDP1 played an important role in cell proliferation and may be a useful therapeutic target in human lung cancer.

Entities:  

Keywords:  CTDP1; Cell growth; Lentivirus; Lung cancer

Mesh:

Substances:

Year:  2015        PMID: 26590573     DOI: 10.1007/s00432-015-2070-7

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  36 in total

Review 1.  CTD phosphatase: role in RNA polymerase II cycling and the regulation of transcript elongation.

Authors:  Patrick S Lin; Nicholas F Marshall; Michael E Dahmus
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2002

2.  Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.

Authors:  H Han; J F Silverman; T S Santucci; R S Macherey; T A d'Amato; M Y Tung; R J Weyant; R J Landreneau
Journal:  Ann Surg Oncol       Date:  2001 Jan-Feb       Impact factor: 5.344

3.  Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer.

Authors:  M Liao; H Wang; Z Lin; J Feng; D Zhu
Journal:  Lung Cancer       Date:  2001 Aug-Sep       Impact factor: 5.705

4.  FCP1, a phosphatase specific for the heptapeptide repeat of the largest subunit of RNA polymerase II, stimulates transcription elongation.

Authors:  Subhrangsu S Mandal; Helen Cho; Sungjoon Kim; Kettly Cabane; Danny Reinberg
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

5.  Survival of cancer cells is maintained by EGFR independent of its kinase activity.

Authors:  Zhang Weihua; Rachel Tsan; Wei-Chien Huang; Qiuyu Wu; Chao-Hua Chiu; Isaiah J Fidler; Mien-Chie Hung
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

Review 6.  Lentiviral delivery of short hairpin RNAs.

Authors:  N Manjunath; Haoquan Wu; Sandesh Subramanya; Premlata Shankar
Journal:  Adv Drug Deliv Rev       Date:  2009-03-31       Impact factor: 15.470

Review 7.  Adjuvant chemotherapy after complete resection for early stage NSCLC.

Authors:  Giorgio Scagliotti; Silvia Novello
Journal:  Lung Cancer       Date:  2003-12       Impact factor: 5.705

Review 8.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

9.  Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial.

Authors:  Edward S Kim; Vera Hirsh; Tony Mok; Mark A Socinski; Radj Gervais; Yi-Long Wu; Long-Yun Li; Claire L Watkins; Mark V Sellers; Elizabeth S Lowe; Yan Sun; Mei-Lin Liao; Kell Osterlind; Martin Reck; Alison A Armour; Frances A Shepherd; Scott M Lippman; Jean-Yves Douillard
Journal:  Lancet       Date:  2008-11-22       Impact factor: 79.321

10.  Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer.

Authors:  T C Mineo; V Ambrogi; A Baldi; C Rabitti; P Bollero; B Vincenzi; G Tonini
Journal:  J Clin Pathol       Date:  2004-06       Impact factor: 3.411

View more
  1 in total

1.  Ctdp1 deficiency leads to early embryonic lethality in mice and defects in cell cycle progression in MEFs.

Authors:  Fangfang Qiao; Henry C-H Law; Kimiko L Krieger; Emalie J Clement; Yi Xiao; Shannon M Buckley; Nicholas T Woods
Journal:  Biol Open       Date:  2021-01-06       Impact factor: 2.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.